Virax Biolabs Group Ltd. (VRAX)
Virax Biolabs Group Market Cap: 1.886M for Jan. 22, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Biodexa Pharmaceuticals Plc | 1.837M |
| NuCana Plc | 13.55M |
| Autolus Therapeutics Plc | 403.21M |
| Tiziana Life Sciences Ltd. | 211.23M |
| Aptorum Group Ltd. | 7.144M |
Market Cap Related Metrics
| PS Ratio | 437.34 |
| Price | 0.2882 |
| Earnings Yield | -434.5% |